Chiao Lo

机构：National Taiwan University Hospital · ORCID：0000-0002-5779-9234

发表论文 59 篇 · 总被引 638 次 · h-index 14

代表论文

• From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer? (2015 · The Journal of Steroid Biochemistry and Molecular Biology · 被引 63)
• The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia – A systematic review and meta-analysis (2019 · Nutrition Metabolism and Cardiovascular Diseases · 被引 56)
• Using next‐generation sequencing to redefineBRCAnessin triple‐negative breast cancer (2020 · Cancer Science · 被引 49)
• Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy (2021 · Frontiers in Oncology · 被引 43)
• Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy (2016 · Annals of Surgical Oncology · 被引 37)
• Serum C-Reactive Protein and Interleukin-6 Levels as Biomarkers for Disease Severity and Clinical Outcomes in Patients with Idiopathic Granulomatous Mastitis (2021 · Journal of Clinical Medicine · 被引 32)